![Robert Zeldin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 M $ in data 31/07/2026
Robert K.
Zeldin is currently Chief Medical Officer at MeiraGTx Holdings Plc since 2020.
Former positions include Chief Medical Officer & Executive Vice President at Acceleron Pharma, Inc. from 2018 to 2019; Chief Medical Officer at Immunovant, Inc. from 2019 to 2020; Chief Medical Officer at Ablynx NV from 2015 to 2018; Senior Vice President-Global Clinical Development at Stallergenes SAS from 2011 to 2015; Vice President at Novartis Pharmaceuticals Corp.
from 2005 to 2010; and Medical Officer roles at the US Food & Drug Administration and the Center for Biologics Evaluation & Research.
Education includes undergraduate studies at The Johns Hopkins University and a doctorate from Tufts University School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 25/06/2026 | 171.801 ( 0,19% ) | 2 M $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MEIRAGTX HOLDINGS PLC | Direttore Tecnico/Scientifico/R&S | 05/08/2020 |
| Società | Posizione | Fine |
|---|---|---|
| IMMUNOVANT, INC. | Direttore Tecnico/Scientifico/R&S | 01/04/2020 |
| ACCELERON PHARMA INC. | Direttore Tecnico/Scientifico/R&S | 05/04/2019 |
| ABLYNX | Direttore Tecnico/Scientifico/R&S | 01/01/2018 |
| STALLERGENES | Direttore Tecnico/Scientifico/R&S | 01/01/2015 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01/01/2010 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Stallergenes SA
 Stallergenes SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products used for the treatment of allergy-related respiratory diseases | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Center for Biologics Evaluation & Research
 Center for Biologics Evaluation & Research Miscellaneous Commercial ServicesCommercial Services Engages in conducting research to promote safe and appropriate use of biological products | Commercial Services |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MeiraGTx Holdings Plc
 MeiraGTx Holdings Plc BiotechnologyHealth Technology Develops and manufactures genetic medicines | Health Technology |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
